Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca Dumont

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|March 21, 2015
Towards tailored radiopeptide therapyPiotr Radojewski, Rebecca Dumont, Nicolas Marincek, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 11, 2017
Reply: Diabetes Mellitus and Its Effects on All-Cause Mortality After Radiopeptide Therapy for Neuroendocrine Tumors: Methodologic IssuesMaria Umlauft, Piotr Radojewski, Petar-Marko Spanjol, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 17, 2016
Diabetes Mellitus and Its Effects on All-Cause Mortality After Radiopeptide Therapy for Neuroendocrine TumorsMaria Umlauft, Piotr Radojewski, Petar-Marko Spanjol, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2008
Development of a real-time RT-PCR assay for detecting EGFRvIII in glioblastoma samplesKoji Yoshimoto, Julie Dang, Shaojun Zhu, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
European Journal of Nuclear Medicine and Molecular Imaging|March 21, 2015
Towards tailored radiopeptide therapyPiotr Radojewski, Rebecca Dumont, Nicolas Marincek, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 11, 2017
Reply: Diabetes Mellitus and Its Effects on All-Cause Mortality After Radiopeptide Therapy for Neuroendocrine Tumors: Methodologic IssuesMaria Umlauft, Piotr Radojewski, Petar-Marko Spanjol, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 17, 2016
Diabetes Mellitus and Its Effects on All-Cause Mortality After Radiopeptide Therapy for Neuroendocrine TumorsMaria Umlauft, Piotr Radojewski, Petar-Marko Spanjol, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2008
Development of a real-time RT-PCR assay for detecting EGFRvIII in glioblastoma samplesKoji Yoshimoto, Julie Dang, Shaojun Zhu, et al.
Pageof 1